COVID Could Impair Men's Sperm for Months: Study at AshTip Solution.

VIENNA — Resolution of non-alcoholic steatohepatitis (NASH), and reduction of fibrosis on liver biopsy were achieved with the oral, thyroid hormone receptor beta-selective agonist resmetirom (Madrigal Pharmaceuticals) in patients with NASH and associated cirrhosis in a pivotal phase 3 clinical trial. The primary results of the MAESTRO-NASH (NCT03900429) trial were reported here at the European Association for the Study of the Liver (EASL) Congress 2023. 2023-06-22

In April 2021, after 13 months of having long COVID and helping conduct two patient-led research studies on the condition with the Patient-Led Research Collaborative (PLRC), I testified to Congress about what was needed to address the crisis. As I Zoomed in from my apartment in Oakland, California, downing my salty water to help tame my tachycardia, I felt hopeful that policymakers were paying attention and would take action. They seemed engaged and concerned as they made remarks and asked questions. 2023-06-29

New research criteria appear to accurately identify athletes in sports such as boxing or martial arts who will go on to develop chronic traumatic encephalopathy (CTE). 2023-07-03

Higher levels of alcohol consumption appear to increase an individual's risk of early-onset colorectal cancer (CRC), particularly distal colon and rectal cancers, according to a population-based study from Korea. 2023-07-07

An estimated 3 in every 10 white-tailed deer in the U.S. have had COVID-19, and new research suggests deer populations could be a source of virus mutations that may be passed to humans. 2023-07-12